169 related articles for article (PubMed ID: 20031934)
21. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA; Donohue JF
Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
[TBL] [Abstract][Full Text] [Related]
22. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
Berim I; Sethi S
Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062
[TBL] [Abstract][Full Text] [Related]
23. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole PJ; Black PN
Cochrane Database Syst Rev; 2000; (2):CD001287. PubMed ID: 10796634
[TBL] [Abstract][Full Text] [Related]
24. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.
Tashkin DP
Curr Opin Pulm Med; 2010 Mar; 16(2):97-105. PubMed ID: 20019615
[TBL] [Abstract][Full Text] [Related]
25. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD.
Cazzola M; Page CP; Wedzicha JA; Celli BR; Anzueto A; Matera MG
Respir Res; 2023 Jul; 24(1):194. PubMed ID: 37517999
[TBL] [Abstract][Full Text] [Related]
26. Maintenance pharmacotherapy of mild and moderate COPD: what is the evidence?
Ferguson GT
Respir Med; 2011 Sep; 105(9):1268-74. PubMed ID: 21353516
[TBL] [Abstract][Full Text] [Related]
27. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
Beeh KM; Beier J
Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368
[TBL] [Abstract][Full Text] [Related]
28. [Chronic obstructive pulmonary disease exacerbation. Do we use all possibilities of outpatient therapy?].
Leshchenko IV
Ter Arkh; 2013; 85(10):83-7. PubMed ID: 24437224
[TBL] [Abstract][Full Text] [Related]
29. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole PJ; Black PN
Cochrane Database Syst Rev; 2003; (2):CD001287. PubMed ID: 12804402
[TBL] [Abstract][Full Text] [Related]
30. Prevention of exacerbations of COPD with pharmacotherapy.
Miravitlles M
Eur Respir Rev; 2010 Jun; 19(116):119-26. PubMed ID: 20956180
[TBL] [Abstract][Full Text] [Related]
31. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review.
Poole PJ; Black PN
BMJ; 2001 May; 322(7297):1271-4. PubMed ID: 11375228
[TBL] [Abstract][Full Text] [Related]
32. Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents.
Poole PJ; Black PN
Am J Respir Med; 2003; 2(5):367-70. PubMed ID: 14719989
[TBL] [Abstract][Full Text] [Related]
33. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.
Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
Pulm Pharmacol Ther; 2018 Feb; 48():185-194. PubMed ID: 29233650
[TBL] [Abstract][Full Text] [Related]
34. Prediction and prevention of exacerbations and mortality in patients with COPD.
Kostikas K; Clemens A; Patalano F
Expert Rev Respir Med; 2016 Jul; 10(7):739-53. PubMed ID: 27135786
[TBL] [Abstract][Full Text] [Related]
35. New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach.
Juergens LJ; Worth H; Juergens UR
Adv Ther; 2020 May; 37(5):1737-1753. PubMed ID: 32200535
[TBL] [Abstract][Full Text] [Related]
36. Clinical Pharmacology of Oral Maintenance Therapies for Obstructive Lung Diseases.
Pleasants RA
Respir Care; 2018 Jun; 63(6):671-689. PubMed ID: 29794203
[TBL] [Abstract][Full Text] [Related]
37. Erdosteine: its relevance in COPD treatment.
Moretti M
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):333-43. PubMed ID: 19331595
[TBL] [Abstract][Full Text] [Related]
38. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
Sadowska AM
Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
[TBL] [Abstract][Full Text] [Related]
39. Mucoactive therapy in COPD.
Decramer M; Janssens W
Eur Respir Rev; 2010 Jun; 19(116):134-40. PubMed ID: 20956182
[TBL] [Abstract][Full Text] [Related]
40. Role of Clarithromycin in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Vora A
J Assoc Physicians India; 2017 Sep; 65(9):100-104. PubMed ID: 29313589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
